BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34904696)

  • 21. Enhancing system-wide implementation of opioid prescribing guidelines in primary care: protocol for a stepped-wedge quality improvement project.
    Zgierska AE; Vidaver RM; Smith P; Ales MW; Nisbet K; Boss D; Tuan WJ; Hahn DL
    BMC Health Serv Res; 2018 Jun; 18(1):415. PubMed ID: 29871625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of a pharmacist-led service for patients at high risk for opioid overdose.
    Tewell R; Edgerton L; Kyle E
    Am J Health Syst Pharm; 2018 Mar; 75(6):376-383. PubMed ID: 29523534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability in opioid prescription monitoring and evidence of aberrant medication taking behaviors in urban safety-net clinics.
    Lange A; Lasser KE; Xuan Z; Khalid L; Beers D; Heymann OD; Shanahan CW; Crosson J; Liebschutz JM
    Pain; 2015 Feb; 156(2):335-340. PubMed ID: 25599455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term opioid therapy tapering: Trends from 2014 to 2018 in a Midwestern State.
    Mazurenko O; Gupta S; Blackburn J; Simon K; Harle CA
    Drug Alcohol Depend; 2021 Nov; 228():109108. PubMed ID: 34688106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
    Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
    J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of the "CDC Guideline for Prescribing Opioids for Chronic Pain" With Emergency Department Opioid Prescribing.
    Dayer LE; Breckling MN; Kling BS; Lakkad M; McDade ER; Painter JT
    J Emerg Med; 2019 Nov; 57(5):597-602. PubMed ID: 31594747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a targeted naloxone coprescribing program in a primary care practice.
    Wilson CG; Rodriguez F; Carrington AC; Fagan EB
    J Am Pharm Assoc (2003); 2017; 57(2S):S130-S134. PubMed ID: 28189537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicomponent intervention to improve adherence to opioid prescribing and monitoring guidelines in primary care.
    Huang KTL; Blazey-Martin D; Chandler D; Wurcel A; Gillis J; Tishler J
    J Opioid Manag; 2019; 15(6):445-453. PubMed ID: 31850506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic urine drug testing for detecting and managing opioid misuse among chronic noncancer pain patients in primary care-The HARMS Program: A retrospective chart review of 77 patients.
    Shahi N; Patchett-Marble R
    J Opioid Manag; 2020; 16(4):277-282. PubMed ID: 32885835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain.
    Coffin PO; Behar E; Rowe C; Santos GM; Coffa D; Bald M; Vittinghoff E
    Ann Intern Med; 2016 Aug; 165(4):245-52. PubMed ID: 27366987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Comprehensive, Multimodal, Interdisciplinary Approach to Chronic Non-Cancer Pain Management in a Family Medicine Clinic: A Retrospective Cohort Review.
    Kwon E; Stange C; Reichlin K; Vernon H; Miyanari A; Bier E; Beydoun H; Kalish V
    Perm J; 2021 Oct; 25():. PubMed ID: 35348080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perceptions and Impact of the 2017 Canadian Guideline for Opioid Therapy and Chronic Noncancer Pain: A Cross-Sectional Study of Canadian Physicians.
    Busse JW; Douglas J; Chauhan TS; Kobeissi B; Blackmer J
    Pain Res Manag; 2020; 2020():8380171. PubMed ID: 32148601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing system-wide implementation of opioid prescribing guidelines in primary care: findings from a non-randomized stepped-wedge quality improvement project.
    Zgierska AE; Robinson JM; Lennon RP; Smith PD; Nisbet K; Ales MW; Boss D; Tuan WJ; Vidaver RM; Hahn DL
    BMC Fam Pract; 2020 Nov; 21(1):245. PubMed ID: 33248458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of higher-risk chronic opioid prescriptions in an academic primary care setting.
    Bauer SR; Hitchner L; Harrison H; Gerstenberger J; Steiger S
    Subst Abus; 2016; 37(1):110-7. PubMed ID: 26848633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality.
    Gaither JR; Goulet JL; Becker WC; Crystal S; Edelman EJ; Gordon K; Kerns RD; Rimland D; Skanderson M; Justice AC; Fiellin DA
    J Gen Intern Med; 2016 May; 31(5):492-501. PubMed ID: 26847447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of chronic nonmalignant pain: a needs assessment in an internal medicine resident continuity clinic.
    Yanni LM; Weaver MF; Johnson BA; Morgan LA; Harrington SE; Ketchum JM
    J Opioid Manag; 2008; 4(4):201-11. PubMed ID: 18837203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guideline-recommended vs high-dose long-term opioid therapy for chronic noncancer pain is associated with better health outcomes: data from a representative sample of the German population.
    Häuser W; Schubert T; Scherbaum N; Tölle T
    Pain; 2018 Jan; 159(1):85-91. PubMed ID: 28953194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.
    Dowell D; Haegerich TM; Chou R
    JAMA; 2016 Apr; 315(15):1624-45. PubMed ID: 26977696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.